Dyer V - Search Results

1

Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer.

Rudek MA, Figg WD, Dyer V, Dahut W, Turner ML, Steinberg SM, Liewehr DJ, Kohler DR, Pluda JM, Reed E. Rudek MA, et al. Among authors: dyer v. J Clin Oncol. 2001 Jan 15;19(2):584-92. doi: 10.1200/JCO.2001.19.2.584. J Clin Oncol. 2001. PMID: 11208854 Clinical Trial.

2

A pharmacokinetically guided Phase II study of carboxyamido-triazole in androgen-independent prostate cancer.

Bauer KS, Figg WD, Hamilton JM, Jones EC, Premkumar A, Steinberg SM, Dyer V, Linehan WM, Pluda JM, Reed E. Bauer KS, et al. Among authors: dyer v. Clin Cancer Res. 1999 Sep;5(9):2324-9. Clin Cancer Res. 1999. PMID: 10499600 Clinical Trial.

3

Reversible sideroblastic anemia associated with the tetracycline analogue COL-3.

Rudek MA, Horne M, Figg WD, Dahut W, Dyer V, Pluda JM, Reed E. Rudek MA, et al. Among authors: dyer v. Am J Hematol. 2001 May;67(1):51-3. doi: 10.1002/ajh.1076. Am J Hematol. 2001. PMID: 11279658 Free article.

4

Drug-induced lupus associated with COL-3: report of 3 cases.

Ghate JV, Turner ML, Rudek MA, Figg WD, Dahut W, Dyer V, Pluda JM, Reed E. Ghate JV, et al. Among authors: dyer v. Arch Dermatol. 2001 Apr;137(4):471-4. Arch Dermatol. 2001. PMID: 11295928 Clinical Trial.

5

Alendronate does not interfere with 99mTc-methylene diphosphonate bone scanning.

Carrasquillo JA, Whatley M, Dyer V, Figg WD, Dahut W. Carrasquillo JA, et al. Among authors: dyer v. J Nucl Med. 2001 Sep;42(9):1359-63. J Nucl Med. 2001. PMID: 11535725 Free article.

6

Lessons Learned from the Impact of COVID-19 on NCI-sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-centric Study Designs.

Samimi G, House M, Benante K, Bengtson L, Budd T, Dermody B, DeShong K, Dyer V, Kimler BF, Sahasrabuddhe VV, Siminski S, Ford LG, Vilar E, Szabo E. Samimi G, et al. Among authors: dyer v. Cancer Prev Res (Phila). 2022 May 3;15(5):279-284. doi: 10.1158/1940-6207.CAPR-21-0578. Cancer Prev Res (Phila). 2022. PMID: 35502553

7

Engaging the Dignity of Risk in Home Hospice Care.

Dyer V, Kirk TW. Dyer V, et al. Perspect Biol Med. 2022;65(2):242-251. doi: 10.1353/pbm.2022.0020. Perspect Biol Med. 2022. PMID: 35938432

8

Genomic features of the Helicobacter pylori strain PMSS1 and its virulence attributes as deduced from its in vivo colonisation patterns.

Dyer V, Brüggemann H, Sörensen M, Kühl AA, Hoffman K, Brinkmann V, Reines MDM, Zimmerman S, Meyer TF, Koch M. Dyer V, et al. Mol Microbiol. 2018 Dec;110(5):761-776. doi: 10.1111/mmi.14123. Epub 2018 Oct 25. Mol Microbiol. 2018. PMID: 30230643 Free article.

9

Helicobacter pylori Depletes Cholesterol in Gastric Glands to Prevent Interferon Gamma Signaling and Escape the Inflammatory Response.

Morey P, Pfannkuch L, Pang E, Boccellato F, Sigal M, Imai-Matsushima A, Dyer V, Koch M, Mollenkopf HJ, Schlaermann P, Meyer TF. Morey P, et al. Among authors: dyer v. Gastroenterology. 2018 Apr;154(5):1391-1404.e9. doi: 10.1053/j.gastro.2017.12.008. Epub 2017 Dec 19. Gastroenterology. 2018. PMID: 29273450 Free article.

10

tRNA Lys3 promoter cassettes that efficiently express RNAi-activating antihepatitis B virus short hairpin RNAs.

Dyer V, Ely A, Bloom K, Weinberg M, Arbuthnot P. Dyer V, et al. Biochem Biophys Res Commun. 2010 Aug 6;398(4):640-6. doi: 10.1016/j.bbrc.2010.06.122. Epub 2010 Jul 1. Biochem Biophys Res Commun. 2010. PMID: 20599752

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters